ReviewBiomedical engineering letters2025
Advances in artificial vision systems: a comprehensive review of technologies, applications, and future directions.
Review in Biomedical engineering letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review article focuses on recent advancements and persistent challenges in artificial vision prostheses designed to restore sight for patients affected by retinal diseases. It comprehensively examines various approaches, including epiretinal, subretinal, and suprachoroidal implants, as well as optic nerve and visual cortex stimulation strategies. The critical role of the retina in visual perception is explored, emphasizing how retinal degeneration affects the transmission of visual information and how artificial devices aim to replicate this function. The review also discusses the technological complexities of artificial retina development, particularly challenges associated with enhancing resolution, minimizing the spread of electrical stimulation, and achieving reliable long-term device functionality within the biological environment. Practical clinical outcomes, such as surgical feasibility, device durability, and biocompatibility, are analyzed in light of these innovations. Furthermore, emerging trends are highlighted, including the adoption of flexible materials, photovoltaic structures, and 3D electrode architectures to improve the performance and longevity of implants. Ultimately, future advancements in artificial vision systems will depend on integrated approaches that combine cutting-edge engineering with a deep understanding of biological systems to achieve meaningful and lasting visual restoration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.